Colgate-Palmolive Company (NYSE:CL) price on Friday, March 17, fall -1.03% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $72.20.
A look at the stock’s price movement, the close in the last trading session was $72.95, moving within a range at $71.83 and $73.05. The beta value (5-Year monthly) was 0.48 while the PE ratio in trailing twelve months stood at 33.99. Turning to its 52-week performance, $83.81 and $67.84 were the 52-week high and 52-week low respectively. Overall, CL moved -0.69% over the past month.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Colgate-Palmolive Company’s market cap currently stands at around $59.98 billion, with investors looking forward to this quarter’s earnings report slated for Apr 28, 2023. The company has a Forward Dividend ratio of 1.88, with its dividend yield at 2.60%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report. Analysts project the company’s earnings per share (EPS) to be $0.71, which has seen fiscal year 2023 EPS growth forecast to increase to $3.11 and about $3.4 for fiscal year 2024. Per the data, EPS growth is expected to be 4.70% for 2023 and 9.30% for the next financial year.
Analysts have a consensus estimate of $4.56 billion for the company’s revenue for the quarter, with a low and high estimate of $4.42 billion and $4.67 billion respectively. The average forecast suggests up to a 3.70% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue for 2023 to grow to $18.77 billion, representing a 4.50% jump on that reported in the last financial year.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that CL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
23 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 13 analyst(s) rate the stock as a Hold, 10 recommend CL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
The technical evaluation for the stock shows the PEG ratio is 5.65, with CL’s current price about -1.02% and -3.02% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 44.28, while 7-day volatility ratio is 1.75% and 1.67% in the 30-day chart. Further, Colgate-Palmolive Company (CL) has a beta value of 0.48, and an average true range (ATR) of 1.23. Analysts have given the company’s stock an average 52-week price target of $81.17, forecast between a low of $67.00 and high of $90.00. Looking at the price targets, the low is 7.2% off current price level while to achieve the yearly target high, price needs to move -24.65%. Nonetheless, investors will most likely welcome a -13.57% jump to $82.00 which is the analysts’ median price.
In the market, a comparison of Colgate-Palmolive Company (CL) and its peers suggest the former has performed considerably weaker. Data shows CL’s intraday price has changed -1.03% in last session and -3.93% over the past year. Comparatively, The Procter & Gamble Company (PG) has moved 0.03% on the day and only -4.56% in the past 12 months. Looking at another peer, we see that Osisko Gold Royalties Ltd (OR) price has gained 5.85% on the day. However, the stock is 6.23% off its price a year ago. If we look at the PE ratio, we find that Colgate-Palmolive Company’s ratio stands at 33.99 compared to The Procter & Gamble Company’s 25.10 and Osisko Gold Royalties Ltd’s 21.79. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -1.10% and -1.19% respectively in the last trading.
If we refocus on Colgate-Palmolive Company (NYSE:CL), historical trading data shows that trading volumes averaged 4.48 million over the past 10 days and 4.17 million over the past 3 months. The company’s latest data on shares outstanding shows there are 832.50 million shares.
The 0.10% of Colgate-Palmolive Company’s shares are in the hands of company insiders while institutional holders own 81.30% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 6.83 million on Jan 12, 2023, giving us a short ratio of 1.88. The data shows that as of Jan 12, 2023 short interest in Colgate-Palmolive Company (CL) stood at 0.82% of shares outstanding, with shares short rising to 6.05 million registered in Dec 14, 2022. Current price change has pushed the stock -8.36% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CL stock continues to rise going into the next quarter.